This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...
Abstract: Driven by the global carbon neutral strategy, the large-scale application of Carbon Capture, Utilization and Storage (CCUS) technology has significantly weakened the peaking margin of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback